Home ›
Trademark Categories ›
Pharmaceuticals ›
2019 ›
NU ›
NUVEMZI
Trademark search for:
NUVEMZI
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2019-08-14 — Application filed
2019-08-17 — Application filed
2019-08-29 — Application filed
2019-10-08 — Final disposition recorded
2019-10-08 — Final disposition recorded
2019-10-08 — Assigned to examiner
2019-10-08 — Final disposition recorded
2019-12-19 — Office action issued
2020-01-13 — Examiners amendment -written
2020-01-13 — Approved for pub - principal register
2020-01-13 — Teas/email correspondence entered
2020-01-13 — Examiners amendment e-mailed
2020-01-13 — Notification of examiners amendment e-mailed
2020-01-13 — Examiner's amendment entered
2020-01-13 — Assigned to lie
2020-01-13 — Correspondence received in law office
2020-01-29 — Notification of notice of publication e-mailed
2020-02-18 — Published for opposition
2020-02-18 — Official gazette publication confirmation e-mailed
2020-03-11 — Opposition instituted no. 999999
2020-03-11 — Opposition papers received at ttab
2020-10-23 — Ttab release case to trademarks
2020-10-23 — Opposition dismissed no. 999999
2020-10-23 — Opposition terminated no. 999999
2020-12-08 — Noa e-mailed - sou required from applicant
2021-06-02 — Sou teas extension received
2021-06-02 — Sou extension 1 filed
2021-06-02 — Sou extension 1 granted
2021-06-04 — Notice of approval of extension request e-mailed
2021-12-07 — Sou teas extension received
2021-12-07 — Sou extension 2 filed
2021-12-07 — Sou extension 2 granted
2021-12-09 — Notice of approval of extension request e-mailed
2021-12-10 — Attorney/dom.rep.revoked and/or appointed
2021-12-10 — Teas change of correspondence received
2021-12-10 — Teas revoke/app/change addr of atty/dom rep received
2022-06-08 — Sou teas extension received
2022-06-08 — Sou extension 3 filed
2022-06-08 — Sou extension 3 granted
2022-06-10 — Notice of approval of extension request e-mailed
2022-11-30 — Sou teas extension received
2022-11-30 — Sou extension 4 granted
2022-11-30 — Sou extension 4 filed
2022-12-06 — Notice of approval of extension request e-mailed
2023-06-06 — Sou teas extension received
2023-06-06 — Sou extension 5 filed
2023-06-12 — Case assigned to intent to use paralegal
2023-06-14 — Sou extension 5 granted
2023-06-15 — Notice of approval of extension request e-mailed
2024-01-08 — Application abandoned
2024-01-08 — Application abandoned
2024-01-08 — Final status recorded
Owner Information
Ovid Therapeutics Inc.
Ovid Therapeutics Inc.
Correspondent
DANNY M AWDEH Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
